Spravato is a prescription nasal spray for adults with certain types of depression. Its active ingredient is esketamine, and it works differently from most oral antidepressants. When you understand how a medication works, you can ask focused questions.
NMDA Receptors and Brain Targeting
Spravato acts on glutamate, the most common chemical messenger in the brain. Nerve cells receive glutamate through receptors on their surface. The brain has NMDA receptors throughout many regions, but areas involved in mood regulation are most relevant to how Spravato works. Your provider can explain which brain regions are most studied in relation to your treatment. Some oral antidepressants target serotonin, norepinephrine, or dopamine. When other treatments have not provided enough relief, your provider may discuss Spravato, but eligibility depends on your full history.
Brain Signaling and Spravato’s Effects
Blocking NMDA receptors leads to a short-term increase in glutamate activity. This increase happens because the brain adjusts its signaling when receptors are blocked, shifting the balance of chemical activity. The extra glutamate activates a second receptor type, called the AMPA receptor. AMPA receptors respond quickly, and their activation sets off a series of downstream changes inside the nerve cell. AMPA activation prompts the release of supportive proteins, including BDNF, or brain-derived neurotrophic factor.
BDNF supports the health of existing nerve cells, and it helps form new cell connections. Your provider will monitor your response over time and adjust your plan as needed. Connections between nerve cells are called synapses. While synapses allow nerve cells to communicate, some providers link depression to fewer synapses in certain brain areas. The brain forms and removes synapses throughout life, and this process is called synaptic plasticity.
Office Treatment Requirements Explained
Since spravato acts on the brain quickly, treatment occurs in person at a healthcare facility. You administer the nasal spray yourself, and a staff member remains present throughout each session. Because the medication can cause temporary effects, you stay on site for at least two hours afterward. Your care team monitors your blood pressure before and at regular intervals during that period. Sessions follow a set schedule your provider outlines at the start of treatment. Plan enough time for both administration and the full observation period. Temporary effects are common, and they typically resolve before you leave the office. Your care team reviews these with you before your first session:
- Dizziness and sleepiness: These are among the most frequently reported effects and may vary in intensity from session to session.
- Nausea: Mild to moderate nausea can occur after administration and usually passes during the observation period.
- Dissociation: This can feel like a sense of separation from your surroundings, thoughts, or perception of time.
Discuss Spravato Today
Spravato blocks NMDA receptors, and it changes glutamate signaling in the brain. This mechanism differs from most oral antidepressants, and it requires supervised, in-office treatment. A consultation is the first step. If you have questions about eligibility, contact your care team. Your provider will review your history and explain each step of the treatment process. You can also ask how the session schedule fits your routine.



